Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Comparison of Biologically Assigned HLA-Identical Versus Haploidentical Related Donor Hematopoietic Stem Cell Transplantation

Blood (2017) 130 (Supplement 1): 4605.

https://doi.org/10.1182/blood.V130.Suppl_1.4605.4605

Published: 2017

Journal Articles

Correlation of Myeloid Derived Suppressor Cells and Response to Standard Chemoimmunotherapy in Diffuse Large B Cell Lymphoma

David M. Foureau, PhD, Qing Zhang, PhD, Lawrence J Druhan, PhD, Ryan Jacobs, MD, Fei Guo, PhD, Steven I Park, MD, Danyu Sun, MD PhD, Edward A Copelan, MD, Belinda Rene Avalos, MD, Nilanjan Ghosh, MD PhD

Blood (2017) 130 (Supplement 1): 4023.

https://doi.org/10.1182/blood.V130.Suppl_1.4023.4023

Published: 2017

Journal Articles

Outcomes of Patients with Newly Diagnosed Aggressive B Cell Lymphoma Presenting with Hepatic and/ or Renal Dysfunction

Nilanjan Ghosh, MD PhD, Jigar Trivedi, MSc, PharmD, Srinivasa Reddy Sanikommu, MD, Myra M Robinson, MSPH, Ryan Jacobs, MD, Steven I Park, MD, Danyu Sun, MD PhD, James T Symanowski, PhD, Taylor Brown, BS, MS, Belinda Rene Avalos, MD, Edward A Copelan, MD

Blood (2017) 130 (Supplement 1): 5225.

https://doi.org/10.1182/blood.V130.Suppl_1.5225.5225

Published: 2017

Journal Articles

NF-κb / STAT3 Signaling Pathway Collaboration in Diffuse Large B-Cell Lymphoma (DLBCL) Cell-of-Origin (COO) Subtypes: Resolution of Myeloid Subversion By Standard Induction Chemotherapy

David Foureau, PhD, Qing Zhang, PhD, Lawrence J. Druhan, PhD, Nury M. Steuerwald, PhD, Fei Guo, Elizabeth Jandrisevits, Belinda R. Avalos, MD, Danyu Sun, MD PhD, Ryan Jacobs, MD, Nilanjan Ghosh, MD PhD

Blood (2016) 128 (22): 4133.

https://doi.org/10.1182/blood.V128.22.4133.4133

Published: 2016

Journal Articles

Optimizing Progenitor Cell Mobilization in Patients with Myeloma: Effect of a Pre-Emptive Day 4 Plerixafor-Based Mobilization Algorithm

Omotayo O. Fasan, MBBS, MRCP, Saad Z Usmani, MD FACP, Danyu Sun, MD PhD, Ryan Jacobs, MD, Carlos Lee, BSc, Jigar Trivedi, MSc, PharmD, Eric Chow, PharmD, Dragos Plesca, PharmD, PhD, Manisha Bhutani, MD, Belinda R. Avalos, MD, Edward A. Copelan, MD FACP

Blood (2016) 128 (22): 2184.

https://doi.org/10.1182/blood.V128.22.2184.2184

Published: 2016

Journal Articles

Efficacy of Standard Dose R-CHOP Alternating with R-HiDAC Followed By ASCT As Initial Therapy of Mantle Cell Lymphoma: Cleveland Clinic Experience

Danyu Sun, MD PhD, Brian T. Hill, MD PhD, Lisa Rybicki, MS, Basel Rouphail, MD, Robert M Dean, MD, Deepa Jagadeesh, MD MPH, Aaron T. Gerds, MD MS, Betty K. Hamilton, MD, Ronald M. Sobecks, MD, Hien K. Duong, MD, Steven Andresen, DO, Navneet S. Majhail, MD MS, Brad Pohlman, MD, Matt E. Kalaycio, MD, Brian J. Bolwell, MD, Mitchell R. Smith, MD PhD

Blood (2014) 124 (21): 1730.

https://doi.org/10.1182/blood.V124.21.1730.1730

Published: 2014

Journal Articles

Combination Of Ibrutinib With ABT-199, a BCL-2 Pathway Inhibitor: Effective Therapeutic Strategy In a Novel Mantle Cell Lymphoma Cell Line Model

Xiaoxian Zhao, PhD, Juraj Bodo, PhD, Danyu Sun, MD, PhD, Jeffrey J. Lin, PhD, Lisa Durkin, Shashirekha Shetty, PhD, Mitchell R. Smith, MD, PhD, Eric D. Hsi, MD

Blood (2013) 122 (21): 645.

https://doi.org/10.1182/blood.V122.21.645.645

Published: 2013

NARROW

Comparison of Biologically Assigned HLA-Identical Versus Haploidentical Related Donor Hematopoietic Stem Cell Transplantation

Correlation of Myeloid Derived Suppressor Cells and Response to Standard Chemoimmunotherapy in Diffuse Large B Cell Lymphoma

Outcomes of Patients with Newly Diagnosed Aggressive B Cell Lymphoma Presenting with Hepatic and/ or Renal Dysfunction

NF-κb / STAT3 Signaling Pathway Collaboration in Diffuse Large B-Cell Lymphoma (DLBCL) Cell-of-Origin (COO) Subtypes: Resolution of Myeloid Subversion By Standard Induction Chemotherapy

Optimizing Progenitor Cell Mobilization in Patients with Myeloma: Effect of a Pre-Emptive Day 4 Plerixafor-Based Mobilization Algorithm

Efficacy of Standard Dose R-CHOP Alternating with R-HiDAC Followed By ASCT As Initial Therapy of Mantle Cell Lymphoma: Cleveland Clinic Experience

Combination Of Ibrutinib With ABT-199, a BCL-2 Pathway Inhibitor: Effective Therapeutic Strategy In a Novel Mantle Cell Lymphoma Cell Line Model

Email alerts

ASH Publications

American Society of Hematology

Comparison of Biologically Assigned HLA-Identical Versus Haploidentical Related Donor Hematopoietic Stem Cell Transplantation

Correlation of Myeloid Derived Suppressor Cells and Response to Standard Chemoimmunotherapy in Diffuse Large B Cell Lymphoma

Outcomes of Patients with Newly Diagnosed Aggressive B Cell Lymphoma Presenting with Hepatic and/ or Renal Dysfunction

NF-κb / STAT3 Signaling Pathway Collaboration in Diffuse Large B-Cell Lymphoma (DLBCL) Cell-of-Origin (COO) Subtypes: Resolution of Myeloid Subversion By Standard Induction Chemotherapy

Optimizing Progenitor Cell Mobilization in Patients with Myeloma: Effect of a Pre-Emptive Day 4 Plerixafor-Based Mobilization Algorithm

Efficacy of Standard Dose R-CHOP Alternating with R-HiDAC Followed By ASCT As Initial Therapy of Mantle Cell Lymphoma: Cleveland Clinic Experience

Combination Of Ibrutinib With ABT-199, a BCL-2 Pathway Inhibitor: Effective Therapeutic Strategy In a Novel Mantle Cell Lymphoma Cell Line Model

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only